- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: human epidermal growth factor 2 negative (HER2-)
Total 105122 results
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerChina, United States, Spain, Hungary, Israel, Korea, Republic of, Taiwan, Belgium, Austria, Russian Federation, Switzerland, Portugal, France, Canada, Italy, United Kingdom, Greece, Japan, Germany, Sweden
-
National Cancer Institute (NCI)TerminatedBreast Carcinoma | Stage IV Breast Cancer | Recurrent Breast CarcinomaUnited States
-
Nuvation Bio Inc.WithdrawnBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the BreastUnited States
-
Asan Medical CenterHoffmann-La RocheCompletedMetastatic or Recurrent Gastric Adenocarcinoma | Her-2 Positive Gastric CancerKorea, Republic of
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2 Positive Breast CarcinomaUnited States
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Breast Neoplasms | Adenocarcinomas | Metastatic Solid Tumors Characterized by HER2/Neu ExpressionUnited States
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | HER2/Neu Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Novartis PharmaceuticalsTerminatedCancerUnited States, Canada
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedBreast CancerUnited States
-
Pravin T.P KaumayaNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoma | EGFR OverexpressionUnited States
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
AstraZenecaCompletedBreast CancerRussian Federation
-
Boehringer IngelheimCompletedBreast NeoplasmsHong Kong, Taiwan, United Kingdom, Russian Federation, India, Poland
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedHER2 Expressing Solid TumoursUnited States, Germany
-
Duke UniversityNational Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Ovarian CancerUnited States
-
Novartis PharmaceuticalsRecruitingBreast CancerGermany, France, Spain, Portugal, Poland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7 | Postmenopausal | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 and other conditionsUnited States
-
Shanghai Zhongshan HospitalUnknownGastric Cancer | HER-2China
-
Hoffmann-La RocheCompletedGastric Cancer | Gastroesophageal Junction CancerKorea, Republic of
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States, Canada, Finland, France, Italy, Spain, Taiwan, United Kingdom
-
Medstar Health Research InstituteGenentech, Inc.TerminatedHER-2 Positive Metastatic Breast CancerUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; NRG Oncology; Breast International Group; Myriad Genetic... and other collaboratorsActive, not recruitingBreast CancerUnited States, Austria, Italy, Spain, Sweden, United Kingdom, Belgium, Poland, France, Switzerland, Canada, Germany, Korea, Republic of, Netherlands, Japan, China, Taiwan, Australia, Argentina, Israel, Hungary, Portugal, Iceland, Puerto...
-
Conde, Bebiana, M.D.Completed
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Malignant Ovarian Clear Cell Tumor | Stage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIB Ovarian... and other conditions
-
Accutar Biotechnology IncTerminated
-
PfizerActive, not recruiting
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingEsophageal Cancer | Esophageal AdenocarcinomaNetherlands
-
Peking University First HospitalNot yet recruiting
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerGermany
-
Hoffmann-La RocheCompletedHER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast CancerIndia
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China
-
Hannover Medical SchoolGerman Center for Infection ResearchRecruiting
-
West Cancer CenterPuma Biotechnology, Inc.; Celcuity IncActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Early-stage Breast CancerUnited States
-
Yi MiaoNanjing Abingen Biotech Co. LtdUnknownGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Bowel Cancer | Liver Cancer | Gallbladder CancerChina
-
BayerCompletedHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
PfizerCompleted
-
RemeGen Co., Ltd.Completed
-
PfizerCompletedBreast NeoplasmsSpain, Korea, Republic of, United States, Australia, Italy, Russian Federation
-
D3 Bio (Wuxi) Co., LtdRecruitingHER-2 Positive Advanced Solid TumorsAustralia, United States, China
-
Eisai Inc.Bliss Biopharmaceutical (Hangzhou) Co., LtdRecruiting
-
Wuhan YZY Biopharma Co., Ltd.Not yet recruitingHER2-Positive Solid Tumors
-
Yale UniversityGenentech, Inc.CompletedHer2-Positive Breast CancerUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Not yet recruitingMetastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IV Colon Cancer AJCC v8 | Stage IV Colorectal Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8United States